# Azithromycin for Meningococcal Carriage

> **NCT06618534** · PHASE2 · RECRUITING · sponsor: **Emory University** · enrollment: 1120 (estimated)

## Conditions studied

- Meningococcal Infections

## Interventions

- **DRUG:** Azithromycin

## Key facts

- **NCT ID:** NCT06618534
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-12
- **Primary completion:** 2026-05
- **Final completion:** 2026-05
- **Target enrollment:** 1120 (ESTIMATED)
- **Last updated:** 2025-11-10

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06618534

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06618534, "Azithromycin for Meningococcal Carriage". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT06618534. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*